Development of an Antiseizure Drug Screening Platform for Dravet Syndrome at the NINDS contract site for the Epilepsy Therapy Screening Program
C. D. Pernici, J. A. Mensah, E. J. Dahle, K. J. Johnson, L. J. Handy, L. L. Buxton, M. D. Smith, P. J. West, C. S. Metcalf, K. S. Wilcox
This paper evaluates a mouse model of Dravet syndrome for antiseizure drug screening, finding that it is highly refractory to common ASDs but responsive to specific treatments like clobazam and valproic acid.
bioRxiv · Dec 1, 2020Pharmacology & Toxicology